FDA Adverse Event Injury Summary report: N

EMBLEM S-ICD

MDR report key: 17012218 · Received May 26, 2023

Report

Report Number
2124215-2023-26718
Event Type
Injury
Date Received
May 26, 2023
Date of Event
June 1, 2015
Report Date
May 26, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO ADDITIONAL INFORMATION IS AVAILABLE. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THE REPORT WILL BE UPDATED AT THAT TIME.

Description of Event or Problem · 0

THIENEL, MANUELA, ET AL. (2022). "IMPAIRMENT OF QUALITY OF LIFE IN PATIENTS WITH IMPLANTED SUBCUTANEOUS CARDIOVERTER DEFIBRILLATOR (S-ICD) COMPARED TO IMPLANTED TRANSVENOUS CARDIOVERTER DEFIBRILLATOR THERAPY". PATIENT PREFERENCE AND ADHERENCE 2022:16 3027-3033. HTTPS://DOI.ORG/10.2147/PPA.S378741. IT WAS REPORTED IN A JOURNAL ARTICLE REVIEW OF 52 PATIENTS IMPLANTED WITH A SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD) AND 52 PATIENTS IMPLANTED WITH A TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (TV-ICD), 27.7% OF S-ICD PATIENTS EXPECTED THEIR QUALITY OF LIFE TO IMPROVE BY EITHER DEACTIVATION OR EXPLANTATION OF THEIR DEVICE. BOTH S-ICD AND TV-ICD GROUPS REPORTED INAPPROPRIATE SHOCK (IAS) THERAPY, WITH A RATE OF 4.8 IAS PER PATIENT YEAR FOR THE S-ICD GROUP. PATIENTS REPORTED PAIN, MENTAL STRESS, AND FEAR AS A RESULT OF THEIR SHOCKS. PATIENT ALSO REPORTED DISCOMFORT AND PAIN FROM THE S-ICD POCKET ITSELF. OF NOTE, THE STUDY LOOKED AT PATIENT IMPLANTED WITH 2ND- OR 3RD-GENERATION S-ICD (BOSTON SCIENTIFIC SERIAL NUMBERS A209 AND A219). NO ADDITIONAL INFORMATION BESIDES THE JOURNAL ARTICLE IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1575965 EMBLEM S-ICD IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LWS BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other